← Eichor
Study identifier: NCT05602376 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

Condition: HIV Infections · Men · Treatment Adherence  ·  Sponsor: Desmond Tutu HIV Foundation

PhaseNA
Planned participants3642
Who can joinMale, 15 Years to no upper limit
Healthy volunteersYes

About this study

This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV. Additionally, the investigators will conduct a multi-method evaluation to inform future implementation of U=U messaging interventions (Aim 3).

This description comes directly from the study's public registry record.

Talk to the study team

Andrew Medina-Marino, PhD  ·  +27 87 821 1109  ·  Andrew.Marino@hiv-research.org.za

Always discuss trial participation with your own doctor first.

Locations (2)

Buffalo City MetroEast London, Eastern Cape, South AfricaRecruiting
Cape Town MetroCape Town, Western Cape, South AfricaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05602376